Surgical removal of the index node marked using magnetic seed localization to assess response to neoadjuvant immunotherapy in patients with stage III melanoma.

Abstract

This pilot study explored the value of localized index node removal after neoadjuvant immunotherapy in patients with stage III melanoma, for use as a response indicator to guide the extent of completion lymph node dissection. Promising technology.

More about this publication

The British journal of surgery
  • Volume 106
  • Issue nr. 5
  • Pages 519-522
  • Publication date 01-04-2019

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.